HaitiDocs
EN FR HT

Data / Partner portfolio / Canada / International Development Research Centre

Prioritizing antimicrobial resistance research, training and governance

Published title: Prioritizing antimicrobial resistance research, training and governance in the Caribbean

US$ millions unless stated. Haitian fiscal year, October to September. FY2026-27 began October 1, 2026.

Description

Antimicrobial resistance (AMR) poses a significant and growing threat to global public health. In 2019, an estimated 1.27 to 4.95 million deaths were attributed to bacterial AMR. The Caribbean region alone accounted for between 7,627 and 30,688 of these deaths. Recent initiatives have aimed to address AMR through strengthening microbiological diagnostics, enhancing surveillance systems, reviewing national action plans, coordinating regional AMR control efforts and conducting situational analyses of AMR risks in the food and agriculture sectors. Despite these efforts, only five CARICOM member countries have developed national action plans and just two countries have published them. In general, data on the AMR burden and risk in the Caribbean is limited, with no countries reporting AMR and antimicrobial use data to

more

the Global AMR Surveillance System. Evidence from published literature is sparse, particularly from the region's lower-middle-income countries. Designing and implementing context-specific research, training and public health interventions requires better data, including gender-disaggregated data on AMR’s drivers, the gendered reach of public health interventions and an understanding of how climate change influences AMR transmission. This project will fund activities to develop an AMR research agenda, reach an agreement on priority topics with AMR stakeholders in the Caribbean and develop plans for implementing a regional research agenda. Activities include stakeholder engagement workshops, leading to a prioritization of an agenda and issuance of proposal development grants to identify future investments in research, training and policy development. The project will also support knowledge mobilization and networking with stakeholders. This project is funded by the People-Centred AMR Research and Innovation Initiative, which is a partnership between IDRC and the United Kingdom Department for Health and Social Care.

Partner
Canada, International Development Research Centre
Sector
Health
Stage
Closed since June 30, 2026
Start
May 12, 2025
Closing
June 30, 2026
Disbursed as of
March 31, 2026
Haiti share
10% of a multi-country award
Implementing agency
Not reported
Effectiveness
Not reported
Last transaction
March 31, 2026
IATI identifier
XM-DAC-301-2-110861-001
Life cycle3 stages, 6 dates

Stage history

StageFrom
Under wayMay 12, 2025
ClosingMarch 12, 2026
ClosedJune 30, 2026

Dates

EventDateSource
Actual startMay 12, 2025IATI
Planned startMay 12, 2025IATI
First disbursementJune 30, 2025Transactions
Planned closing dateMarch 12, 2026IATI
Last disbursementMarch 31, 2026Transactions
Actual closing dateJune 30, 2026IATI

Disbursed in FY2025-26: US$<0.1 million.

Financing

Table 1.Position at the data date by source (stocks), US$ millions

This pageUS$ millionsSource
CommitmentNot reported
Disbursed<0.1IATI
UndisbursedThe balance each partner reports as not yet disbursed, summed only when every operation in scope reports it.Not reported
Total costNot reported

IATI amounts. Approved: The commitments the partner reports, converted to US$. Disbursed to date: The disbursements (IATI transaction type 3, funds paid to another organization) and expenditure (type 4, funds spent by the publisher) the partner reports, converted to US$. Undisbursed: The undisbursed balance the record gives, where the partner reports one, in US$. Amounts by source

Changes to the operationnot reported
Original closing date
Not reported
Closing date extensions
Not reported
Restructurings
Not reported
Emergency component
Not reported

Disbursements by fiscal year

Disbursements, US$ millions
FY2024-25, US$<0.1 million<0.124-25FY2025-26, US$<0.1 million<0.125-26FY2024-25, US$<0.1 million<0.124-25FY2025-26, US$<0.1 million<0.125-26

Table 2.Disbursements by fiscal year, US$ millions

FY2024-25US$ millionsFY2025-26US$ millions
Disbursements<0.1<0.1
Cumulative disbursements<0.1<0.1

Records and documents

Transactions2 transactions, June 30, 2025 to March 31, 2026

Table 3.Transactions, US$ millions

DateMeasureAmountUS$ millionsSourceMethod
June 30, 2025Disbursements<0.1IATIIATI expenditure (transaction type 4), spent by the publisher
March 31, 2026Disbursements<0.1IATIIATI expenditure (transaction type 4), spent by the publisher
Terms5 of 6 reported
Finance type
110 Standard grant
Flow type
10 Official development assistance
Aid type
D02 Other technical assistance
Tied status
5 Untied
Collaboration type
1 Bilateral
Humanitarian
Not reported
Policy markers9 policy markers
Policy markerSignificanceSource
Gender equalitySignificant objectiveIATI
EnvironmentNot targetedIATI
Participatory development and good governanceNot targetedIATI
Trade developmentNot targetedIATI
BiodiversitySignificant objectiveIATI
Climate change mitigationSignificant objectiveIATI
Climate change adaptationSignificant objectiveIATI
DesertificationNot targetedIATI
Reproductive, maternal, newborn and child healthNot targetedIATI
Funds transferred onward3 transactions
RecipientTransactionDateUS$ millions
Various SuppliersExpenditureMarch 31, 2026<0.1
Various SuppliersExpenditureJune 30, 2025<0.1
Various SuppliersExpenditureJune 30, 2025<0.1
Identifiers1 identifier
SystemIdentifierSource
IATI identifierXM-DAC-301-2-110861-001IATI

Partner documents

No document is listed for this operation.

Sources

Data as of October 18, 2026
SourceAccessed on
IATIOctober 18, 2026
IATIOctober 18, 2026
Cite this page

HaitiDocs. Prioritizing antimicrobial resistance research, training and governance. Partner portfolio, data as of October 18, 2026. https://www.haitidocs.org/portfolio/projects/IATI%3AXM-DAC-301-2-110861-001